Susceptibilities of Candida albicans Mouth Isolates to Antifungal Agents, Essentials Oils and Mouth Rinses

Mycopathologia

Volumn 174, Issue 1, 2012, Pages 69-76

  Carvalhinho, Sara ^a,d   Costa, Ana Margarida ^a   Coelho, Ana Cláudia ^b   Martins, Eugénio ^c   Sampaio, Ana ^a,d  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Antifungal; Candida albicans; Essential oils; Mouth rinses; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT; ESSENTIAL OIL; PLANT EXTRACT; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CANDIDA ALBICANS; CHEMISTRY; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH; PLANT;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH; OILS, VOLATILE; PLANT EXTRACTS; PLANTS;

CANDIDA ALBICANS; CINNAMOMUM VERUM; CITRUS LIMON; CITRUS RETICULATA; COMMIPHORA; EUCALYPTUS; MENTHA; ROSMARINUS OFFICINALIS;

EID: 84862022384     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9520-4     Document Type: Article

References (47)

1. Farias N, Buffon M, Cini R. In vitro evaluation of antifungal action of chlorhexidine digluconate and nystatin on the growing control of Candida albicans. Visão Acadêmica Curitiba. 2003; 4: 83-8.
2. Budtz-Jorgensen E. Etiology, pathogenesis, therapy and prophylaxis of yeast infection. Acta Odontol Scand. 1990; 48: 61-9.
3. Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol. 1994; 78: 211-5.
4. Odds F. Candida and Candidosis. In: Odds F, editor. Factors that predispose the host to candidosis. 2nd ed. London: Bailiière Tindal; 1988. p. 71-4.
5. Pinto PM, Weikert-Oliveira RCB, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Microbiol Res. 2008; 163: 579-85.
6. Klepser ME. Antifungal resistance among Candida species. Pharmacother. 2001; 21: 124S-32S.
7. Khan ZU, Chandy R, Metwali KE. Candida albicans strain carriage in patients and nursing staff of an intensive care unit: a study of morphotypes and resistotypes. Mycoses. 2003; 46: 476-86.
8. Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral Candida to seven antifungal agents. Oral Microbiol Immunol. 2005; 20: 349-53.
9. Paniagua GLC, Monroy EP, Negrete EA, Vaca SP. Susceptibility to 5-Fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients. Rev Latinoam Microbiol. 2002; 44: 65-8.
10. Manfredi M, McCullough MJ, Polonelli L, Conti S, Al-Karaawi ZM, Vescovi P, Porter SR. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol. 2006; 21: 177-82.
11. Hiom SJ, Furr JR, Russel AD, Dickinson JR. Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae. J Appl Bacteriol. 1992; 72: 35-40.
12. Giuliana G, Pizzo G, Milici E, Musotto GC, Giangreco R. In vitro antifungal properties of mouthrinses containing antimicrobial agents. J Periodontol. 1997; 68: 729-33.
13. Harper RP, Milsom S, Wade W, Addy M, Moran J, Newcombe RG. An approach to efficacy screening of mouthrinses: studies on a group of French products. (II). Inhibition of salivary bacteria and plaque in vivo. J Clin Periodontol. 1995; 22: 723-7.
14. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils-a review. Food Chemical Toxicol. 2008; 46: 446-75.
15. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol. 1999; 86: 985-90.
16. Giordani R, Regli P, Kaloustian J, Mikaïl C, Abou L, Portugal H. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother Res. 2004; 18: 990-5.
17. Cavaleiro C, Pinto E, Gonçalves MJ, Salgueiro L. Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J Appl Microbiol. 2006; 100: 1333-8.
18. Kurtzman CP, Fell JW. The yeasts: a taxonomic study. 4th ed. Amsterdam: Elsevier; 1998.
19. Taschdjian CL. Routine identification of Candida albicans: current methods on a new medium. Mycologia. 1957; 49: 332-8.
20. Brown AJ, Gow NA. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol. 1999; 7: 333-8.
21. NCCLS. Method for antifungal disk diffusion susceptibility testing for yeasts. Approved Guideline NCCLS Document M44-A. Pennsylvania; 2004.
22. Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 2002; 46: 1781-4.
23. Barry A, Bille J, Brown S, Ellis D, Meis J, Pfaller M, Rennie R, Rinaldi M, Rogers T, Traczewski M. Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol. 2003; 41: 3410-2.
24. StatSoft, Inc. STATISTICA (data analysis software system), version 9. 1. www. statsoft. com; 2010.
25. Hibino K, Wong RW, Hägg U, Samaranayake LP. The effects of orthodontic appliances on Candida in the human mouth. Int J Paediatr Dent. 2009; 19: 301-8.
26. Pai MB, Prashant GM, Murlikrishna KS, Shivakumar KM, Chandu GN. Antifungal efficacy of Punica granatum, Acacia nilotica, Cuminum cyminum and Foeniculum vulgare on Candida albicans: an in vitro study. Indian J Dent Res. 2010; 21: 334-6.
27. Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010; 98: 15-25.
28. Dar-Odeh N, Shehabi A. Oral candidosis in patients with removable dentures. Mycoses. 2003; 46: 187-91.
29. Dorocka-Bobkowska B, Konopka K. Susceptibility of Candida isolates from denture-related stomatitis to antifungal agents in vitro. Int J Prosthodont. 2007; 20: 504-6.
30. Arendrup M, Lundgren B, Jensen IM, Hansen BS, Frimodt-Møller N. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother. 2001; 47: 521-6.
31. Barasch A, Griffin AV. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol. 2008; 3: 265-9.
32. Marcos-Arias C, Eraso E, Madariaga L, Carrilo-Muñoz AJ, Quindós G. In vitro activities of new triazole antifungal agents posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis. Mycopathologia. 2012; 173: 35-46.
33. Giuliana G, Pizzo G, Milici E, Giangreco R. In vitro study of antimicrobial agents against Candida species. Oral Surg Oral Med Oral Pathol. 1999; 1: 44-9.
34. Vianna M, Gomes B, Berber V, Zaia A, Ferraz C. In vitro evaluation of the antimicrobial activity of chlorhexidine and sodium hypoclorite. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97: 79-84.
35. Waltimo T, Haapasalo M, Zehnder M, Meyer J. Clinical aspects related to endodontic yeasts infections. Endod Topics. 2004; 9: 66-78.
36. Janssen AM, Chin NLJ, Scheffer JJC, Svendsen AB. Screening for antimicrobial activity of some essential oils by the agar overlay technique. Pharm Weekbl Sci Ed. 1986; 8: 289-92.
37. Abdel-Mallek AY, Bagy MMK, Hasan HAH. The in vitro anti-yeast activity of some essential oils. J Islam Acad Sci. 1994; 7: 10-2.
38. Ezzat SM. In vitro inhibition of Candida albicans growth by plant extracts and essential oils. World J Microbiol Biotechnol. 2001; 17: 757-9.
39. Işcan G, Kirimer N, Kürkcüoǧlu M, Başer KHC, Demirci F. Antimicrobial screening of Mentha piperita essential oils. J Agric Food Chem. 2002; 50: 3943-6.
40. Tampieri MP, Caluppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathol. 2005; 159: 339-45.
41. Moreira ACP, Lima EO, Souza EL, van Dingenen MA, Trajano VN. Inhibitory effect of Cinnamomum zeylanicum Blume (lauraceae) essential oil and β-pinene on the growth of dematiaceous moulds. Braz J Microbiol. 2007; 38: 33-8.
42. Pozzatti P, Loreto ES, Lopes PGM, Atayde ML, Santurio JM, Alves SH. Comparison of the susceptibilities of clinical isolates of Candidaalbicans and Candida dubliniensis to essential oils. Mycoses. 2009; 53: 12-5.
43. Bullerman LB, Lieu FY, Sally AS. Inhibition of growth and aflatoxin production by cinnamon and clove oils, cinnamoldehyd and eugenol. J Food Sci. 1977; 42: 1107-8.
44. Cheng S-S, Liu J-Y, Hsui Y-R, Chang S-T. Chemical polymorphism and antifungal activity of essential oils from leaves of different provenances of indigenous cinnamon (Cinnamomum osmophloeum). Bioresour Technol. 2006; 97: 306-12.
45. Pozzatti P, Scheid LA, Spader TB, Atayde ML, Santurio JM, Alves SH. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. Can J Microbiol. 2008; 54: 950-6.
46. Devkatte AN, Zore GB, Karuppayil SM. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res. 2005; 5: 867-73.
47. Farag RS, Daw ZY, Hewedi FM, El-Baroty GSA. Antimicrobial activity of some Egyptian spice essential oils. J Food Prot. 1989; 52: 665-7.